Many individual with intellectual disability (ID) can collaborate and communicate opinionsregarding pharmacologic interventions. Like those with typical cognitive ability, they sufferphysical and emotional pain, complicated by varying limitations in communication, and intheir ability to meet basic needs and in navigating social settings. Their communicativeabilities are affected by their degree of ID, ranging from mild to profound, but all individualsshould be afforded the opportunity to communicate their thoughts about treatment in theirown ways and within their developmental frameworks.